Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ·Healthcare·Biotechnology
$38.05
+0.13%
Mkt Cap $2.21B
Analyst Ratings
Buy
10
Hold
2
Sell
0
Price Target (27 analysts)
$41.33
Range $32.00 – $55.00
Implied Upside
+8.6%
Consensus $41.33 vs current $38.05
NASDAQ·Healthcare·Biotechnology
$38.05
+0.13%
Mkt Cap $2.21B
Buy
10
Hold
2
Sell
0
Price Target (27 analysts)
$41.33
Range $32.00 – $55.00
+8.6%
Consensus $41.33 vs current $38.05